Combined Drug Action of 2-Phenylimidazo[2,1-b]Benzothiazole Derivatives on Cancer Cells According to Their Oncogenic Molecular Signatures

The development of targeted molecular therapies has provided remarkable advances into the treatment of human cancers. However, in most tumors the selective pressure triggered by anticancer agents encourages cancer cells to acquire resistance mechanisms. The generation of new rationally designed targ...

Descripción completa

Detalles Bibliográficos
Autores principales: Furlan, Alessandro, Roux, Benjamin, Lamballe, Fabienne, Conti, Filippo, Issaly, Nathalie, Daian, Fabrice, Guillemot, Jean-François, Richelme, Sylvie, Contensin, Magali, Bosch, Joan, Passarella, Daniele, Piccolo, Oreste, Dono, Rosanna, Maina, Flavio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465283/
https://www.ncbi.nlm.nih.gov/pubmed/23071625
http://dx.doi.org/10.1371/journal.pone.0046738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465283/
https://www.ncbi.nlm.nih.gov/pubmed/23071625
http://dx.doi.org/10.1371/journal.pone.0046738

Ejemplares similares